Raz I - Search Results

1

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

Raslová K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N. Raslová K, et al. Among authors: raz i. Diabetes Res Clin Pract. 2004 Nov;66(2):193-201. doi: 10.1016/j.diabres.2004.03.003. Diabetes Res Clin Pract. 2004. PMID: 15533587 Clinical Trial.

2

Association of hyperglycemia and insulin with diabetic cardiovascular complications.

Khamaisi M, Wainstein J, Hancu N, Milicevic Z, Raz I. Khamaisi M, et al. Among authors: raz i. Isr Med Assoc J. 2003 Feb;5(2):116-9. Isr Med Assoc J. 2003. PMID: 12674662 Free article. Review.

3

Diet and coronary heart disease in diabetes.

Cernea S, Hâncu N, Raz I. Cernea S, et al. Among authors: raz i. Acta Diabetol. 2003 Dec;40 Suppl 2:S389-400. doi: 10.1007/s00592-003-0125-8. Acta Diabetol. 2003. PMID: 14704874 Review.

4

Early use of insulin in type 2 diabetes.

Eldor R, Stern E, Milicevic Z, Raz I. Eldor R, et al. Among authors: raz i. Diabetes Res Clin Pract. 2005 Jun;68 Suppl1:S30-5. doi: 10.1016/j.diabres.2005.03.004. Epub 2005 Mar 31. Diabetes Res Clin Pract. 2005. PMID: 15955372 Review.

5

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators. Wiviott SD, et al. Among authors: raz i. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.

6

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.

Raz I, Mouritzen U, Vaz J, Hershkovitz T, Wainstein J, Harman-Boehm I. Raz I, et al. Clin Ther. 2003 Dec;25(12):3109-23. doi: 10.1016/s0149-2918(03)90095-6. Clin Ther. 2003. PMID: 14749149 Clinical Trial.

7

Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design.

Milicevic Z, Raz I, Strojek K, Skrha J, Tan MH, Wyatt JW, Beattie SD, Robbins DC; HEART2D Study. Milicevic Z, et al. Among authors: raz i. J Diabetes Complications. 2005 Mar-Apr;19(2):80-7. doi: 10.1016/j.jdiacomp.2004.06.003. J Diabetes Complications. 2005. PMID: 15745837 Clinical Trial.

8

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, Chow CC, Shaban J. Raz I, et al. Clin Ther. 2005 Sep;27(9):1432-43. doi: 10.1016/j.clinthera.2005.09.001. Clin Ther. 2005. PMID: 16291416 Clinical Trial.

9

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ. Raz I, et al. Diabetes Care. 2009 Mar;32(3):381-6. doi: 10.2337/dc08-1671. Diabetes Care. 2009. PMID: 19246588 Free PMC article. Clinical Trial.

10

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Chacra AR, Tan GH, Apanovitch A, Ravichandran S, List J, Chen R; CV181-040 Investigators. Chacra AR, et al. Int J Clin Pract. 2009 Sep;63(9):1395-406. doi: 10.1111/j.1742-1241.2009.02143.x. Epub 2009 Jul 15. Int J Clin Pract. 2009. PMID: 19614786 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page